WO2003015748A3 - Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds - Google Patents
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds Download PDFInfo
- Publication number
- WO2003015748A3 WO2003015748A3 PCT/US2002/026083 US0226083W WO03015748A3 WO 2003015748 A3 WO2003015748 A3 WO 2003015748A3 US 0226083 W US0226083 W US 0226083W WO 03015748 A3 WO03015748 A3 WO 03015748A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceuticals
- active compounds
- drug delivery
- delivery device
- controlled administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003520708A JP2005504763A (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive corrosive drug delivery device for controlled administration of pharmaceuticals and other active compounds |
IL16041902A IL160419A0 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
NZ531766A NZ531766A (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
MXPA04001491A MXPA04001491A (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds. |
KR10-2004-7002303A KR20040039290A (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
EP02761390A EP1418889A2 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
AU2002326664A AU2002326664B2 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
HU0401281A HUP0401281A3 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals |
CA002459692A CA2459692A1 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
IL160410A IL160410A (en) | 2001-08-16 | 2004-02-16 | Method and system for efficiently transmitting encoded communication signals |
IS7155A IS7155A (en) | 2001-08-16 | 2004-02-16 | Antimicrobial and destructive drug delivery devices for controlled administration of drugs and other active substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/931,319 | 2001-08-16 | ||
US09/931,319 US6585997B2 (en) | 2001-08-16 | 2001-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003015748A2 WO2003015748A2 (en) | 2003-02-27 |
WO2003015748A3 true WO2003015748A3 (en) | 2003-12-04 |
Family
ID=25460591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026083 WO2003015748A2 (en) | 2001-08-16 | 2002-08-16 | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
Country Status (16)
Country | Link |
---|---|
US (2) | US6585997B2 (en) |
EP (1) | EP1418889A2 (en) |
JP (2) | JP2005504763A (en) |
KR (1) | KR20040039290A (en) |
CN (2) | CN101849924A (en) |
AU (1) | AU2002326664B2 (en) |
CA (1) | CA2459692A1 (en) |
HU (1) | HUP0401281A3 (en) |
IL (2) | IL160419A0 (en) |
IS (1) | IS7155A (en) |
MX (1) | MXPA04001491A (en) |
NZ (1) | NZ531766A (en) |
PL (1) | PL373327A1 (en) |
RU (1) | RU2343903C2 (en) |
WO (1) | WO2003015748A2 (en) |
ZA (1) | ZA200402067B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858978B2 (en) | 2004-09-28 | 2014-10-14 | Atrium Medical Corporation | Heat cured gel and method of making |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9220820B2 (en) | 2005-10-15 | 2015-12-29 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
US9592324B2 (en) | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
Families Citing this family (266)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19646392A1 (en) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery |
US20020018754A1 (en) * | 1999-03-15 | 2002-02-14 | Paul Albert Sagel | Shapes for tooth whitening strips |
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
KR20020032521A (en) | 1999-07-02 | 2002-05-03 | 데이비드 엠 모이어 | Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
ES2587187T3 (en) | 2001-05-01 | 2016-10-21 | A. V. Topchiev Institute Of Petrochemical Synthesis | Biphasic water absorbent bioadhesive composition |
JP4116447B2 (en) | 2001-05-01 | 2008-07-09 | エイ.ブイ.トップチーブ インスティテュート オブ ペトロケミカル シンセシス | Hydrogel composition |
US8206738B2 (en) * | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
US20030068375A1 (en) * | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
US20060073174A1 (en) * | 2001-08-16 | 2006-04-06 | Access Pharmaceuticals, Inc. | Adherent and erodible film to treat a moist surface of a body tissue |
US20110092677A1 (en) * | 2001-08-30 | 2011-04-21 | Biorexis Technology, Inc. | Modified transferin-antibody fusion proteins |
US8425892B2 (en) * | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
US7201930B2 (en) * | 2001-11-05 | 2007-04-10 | Haley Jeffrey T | Licorice root extract oral patch for treating canker sores |
US20030099691A1 (en) * | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Films containing starch |
US20030124178A1 (en) * | 2001-12-28 | 2003-07-03 | Haley Jeffrey T. | Soft, adherent, soluble oral patch |
US20030224090A1 (en) * | 2002-02-11 | 2003-12-04 | Edizone, Lc | Snacks of orally soluble edible films |
US20050100515A1 (en) * | 2002-09-11 | 2005-05-12 | The Procter & Gamble Company | Tooth whitening products |
US20050019277A1 (en) * | 2002-09-11 | 2005-01-27 | The Procter & Gamble Company | Tooth whitening products |
US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
US20040131662A1 (en) | 2003-11-12 | 2004-07-08 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
CA2505833A1 (en) * | 2002-11-14 | 2004-06-03 | Innozen, Inc. | Edible film for relief of cough or symptoms associated with pharyngitis |
US8999372B2 (en) | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
US9561182B2 (en) * | 2003-08-22 | 2017-02-07 | Cure Pharmaceutical Corporation | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals |
US20040191302A1 (en) | 2003-03-28 | 2004-09-30 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
ES2496102T3 (en) * | 2003-03-28 | 2014-09-18 | Sigmoid Pharma Limited | Solid oral dosage form containing seamless microcapsules |
WO2004103328A1 (en) * | 2003-04-30 | 2004-12-02 | Icure Pharmaceutical Corporation | Patch for tooth whitening |
US7306812B2 (en) * | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7056118B2 (en) * | 2003-05-27 | 2006-06-06 | Ultradent Products, Inc. | Compositions and devices having a tray-like configuration for delivering a medicament and methods of manufacturing and using such compositions and devices |
US20040241151A1 (en) * | 2003-05-27 | 2004-12-02 | Sca Hygiene Products Ab | Polymer matrix with lactic acid producing bacteria |
US7172423B2 (en) * | 2003-05-27 | 2007-02-06 | Ultradent Products, Inc. | Substantially solid bleaching or treatment compositions in the form of inserts for dental trays, and kits comprising such inserts and trays |
US7472655B2 (en) * | 2003-07-01 | 2009-01-06 | Lu Hao Leng | Table top |
US8313775B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
EP1653925A1 (en) | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
EP1660056A4 (en) * | 2003-08-15 | 2008-12-17 | Arius Two Inc | Adhesive bioerodible transmucosal drug delivery system |
JP5686494B2 (en) | 2003-08-29 | 2015-03-18 | シオノギ インコーポレイテッド | Antibiotic preparations, their use and preparation |
JP2007513869A (en) | 2003-09-15 | 2007-05-31 | アドバンシス ファーマスーティカル コーポレイション | Antibiotic preparations, their use and preparation |
CA2441466A1 (en) * | 2003-09-18 | 2005-03-18 | Aquadomehome Ontario Ltd. | Submergible terrarium |
CA2544624C (en) * | 2003-11-03 | 2011-01-25 | Medtrade Products Limited | Tooth-whitening composition |
US8658201B2 (en) | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
US20050196348A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Stabilized peroxide compositions |
US20050196355A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Film products having controlled disintegration properties |
US20070269519A1 (en) * | 2004-03-03 | 2007-11-22 | Constantine Georgiades | Whitening products |
US20050196354A1 (en) * | 2004-03-03 | 2005-09-08 | Andre Soshinsky | Film compositions |
US20080003248A1 (en) * | 2004-03-03 | 2008-01-03 | Constantine Georgiades | Whitening products |
US20070190125A1 (en) * | 2004-03-03 | 2007-08-16 | Constantine Georgiades | Positioning feature for aiding use of film or strip product |
WO2005102287A2 (en) * | 2004-04-22 | 2005-11-03 | Duocort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
US20050249678A1 (en) | 2004-05-10 | 2005-11-10 | Mahmoud Hassan | Multilayer tooth whitening strips |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
CA2470463C (en) * | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
HUE037643T2 (en) | 2004-06-12 | 2018-09-28 | Collegium Pharmaceutical Inc | Abuse-deterrent drug formulations |
US8715727B2 (en) | 2004-07-02 | 2014-05-06 | Shionogi Inc. | Tablet for pulsed delivery |
PT1793799E (en) * | 2004-08-02 | 2010-07-29 | Glaxosmithkline Consumer Healt | Novel composition for treating xerostomia |
ES2526700T3 (en) | 2004-08-05 | 2015-01-14 | Corium International, Inc. | Adhesive composition |
CA2518650A1 (en) * | 2004-09-10 | 2006-03-10 | Dimitrios Dimitrakoudis | Clostridium botulinum toxin formulation and method for reducing weight |
WO2006035418A2 (en) * | 2004-09-27 | 2006-04-06 | Sigmoid Biotechnologies Limited | Microcapsules comprising a methylxanthine and a corticosteroid |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
WO2006036967A1 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
DE102004049740B4 (en) * | 2004-10-13 | 2009-08-27 | Lts Lohmann Therapie-Systeme Ag | Self-adhesive tooth foil and method for producing the dental foil |
AR051397A1 (en) * | 2004-10-21 | 2007-01-10 | Novartis Ag | PHARMACEUTICAL COMPOSITION |
KR101217680B1 (en) * | 2004-12-09 | 2013-01-02 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | Stabilisation of glucocorticoid esters with acids |
US20060134201A1 (en) * | 2004-12-16 | 2006-06-22 | Haley Jeffrey T | Collagen troches for treating mouth lesions |
GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
DE102005015128B4 (en) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafers containing steroid hormones |
US9023382B2 (en) * | 2005-06-08 | 2015-05-05 | Basf Corporation | Medicament carrier composition and method of forming a film therefrom |
US20060281775A1 (en) | 2005-06-14 | 2006-12-14 | Applied Pharmacy Services, Inc. | Two-component pharmaceutical composition for the treatment of pain |
ES2675228T3 (en) * | 2005-06-17 | 2018-07-09 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods to protect cells during cancer chemotherapy and radiation therapy |
US20080242642A1 (en) | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US8722650B1 (en) | 2005-06-24 | 2014-05-13 | Medicis Pharmaceutical Corporation | Extended-release minocycline dosage forms |
US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
US8252776B2 (en) * | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US8137658B2 (en) | 2005-06-28 | 2012-03-20 | Isp Investments Inc. | Tooth whitening compositions |
CA2612729C (en) * | 2005-07-01 | 2018-02-27 | Kane Biotech Inc. | Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices |
US20070042027A1 (en) * | 2005-08-22 | 2007-02-22 | Haley Jeffrey T | Water soluble anesthetic in an oral patch of hydrophilic gums |
KR20070057660A (en) * | 2005-12-01 | 2007-06-07 | 롬 앤드 하아스 컴패니 | Aqueous polymer dispersions for stabilizing actives |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
BRPI0619806A2 (en) * | 2005-12-13 | 2011-10-18 | Biodelivery Sciences Int Inc | abuse resistant transmucosal drug delivery device |
JP5657206B2 (en) | 2005-12-21 | 2015-01-21 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | Cleaning and / or gloss compositions and methods of use thereof |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
ATE493118T1 (en) * | 2006-01-19 | 2011-01-15 | Dow Global Technologies Inc | BIOLOGICALLY EFFECTIVE COMPOSITION WITH ETHYLCELLULOSE |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20070192438A1 (en) * | 2006-02-10 | 2007-08-16 | Esmond Goei | System and method for on-demand delivery of media products |
US20070192183A1 (en) * | 2006-02-10 | 2007-08-16 | Tovin Monaco | System and architecture for providing retail buying options to consumer using customer data |
US20070192182A1 (en) * | 2006-02-10 | 2007-08-16 | Tovin Monaco | Method of delivering coupons using customer data |
US20070190013A1 (en) * | 2006-02-13 | 2007-08-16 | Yeli Zhang | Film and film-forming compositions |
US8349120B2 (en) * | 2006-03-07 | 2013-01-08 | Ora Health Corporation | Multi-layer patch made on a sheet and enclosed in a blister |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8465759B2 (en) * | 2006-03-24 | 2013-06-18 | Auxilium Us Holdings, Llc | Process for the preparation of a hot-melt extruded laminate |
US8173152B2 (en) | 2006-03-24 | 2012-05-08 | Auxilium Us Holdings, Llc | Stabilized compositions containing alkaline labile drugs |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US20070248655A1 (en) * | 2006-04-21 | 2007-10-25 | Haley Jeffrey T | Lenticular shaped protective mouth sore discs |
US20070248654A1 (en) * | 2006-04-21 | 2007-10-25 | Haley Jeffrey T | Protective mouth sore discs made with corn starch |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US20070264487A1 (en) * | 2006-05-12 | 2007-11-15 | Dean Georgiades | Treated film strips |
CN1850059B (en) * | 2006-05-29 | 2010-05-12 | 王法平 | Amlexanox oral membrane, and its preparing method |
US20070289596A1 (en) * | 2006-06-14 | 2007-12-20 | Campbell Shannon E | Endotracheal cuff and technique for using the same |
WO2008035361A2 (en) * | 2006-06-14 | 2008-03-27 | Arrow Coated Products Ltd | Device for delivering active ingredients to humans, animals and plants |
US20070298087A1 (en) * | 2006-06-27 | 2007-12-27 | Biegajski James E | Two-phase mucoadhesive composition |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
CA2655793A1 (en) | 2006-06-29 | 2008-01-03 | Boston Scientific Limited | Medical devices with selective coating |
US9682256B2 (en) * | 2006-07-14 | 2017-06-20 | Colgate-Palmolive Company | Methods of making compositions comprising films |
BRPI0714712B8 (en) * | 2006-07-21 | 2021-05-25 | Biodelivery Sciences Int Inc | drug delivery device |
JP2009545407A (en) | 2006-08-02 | 2009-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | End prosthesis with 3D decomposition control |
EP1897543A1 (en) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Buprenorphine- wafer for drug substitution therapy |
JP2010503469A (en) | 2006-09-14 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device having drug-eluting film |
WO2008034013A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
JP2010503489A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Biodegradable endoprosthesis and method for producing the same |
WO2008034066A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
DE602007011114D1 (en) | 2006-09-15 | 2011-01-20 | Boston Scient Scimed Inc | BIODEGRADABLE ENDOPROTHESIS WITH BIOSTABILES INORGANIC LAYERS |
WO2008036548A2 (en) | 2006-09-18 | 2008-03-27 | Boston Scientific Limited | Endoprostheses |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US20080140106A1 (en) * | 2006-12-12 | 2008-06-12 | Kimberly-Clark Worldwide, Inc. | Enhanced cuff sealing for endotracheal tubes |
ES2506144T3 (en) | 2006-12-28 | 2014-10-13 | Boston Scientific Limited | Bioerodible endoprosthesis and their manufacturing procedure |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
MX351611B (en) * | 2007-03-29 | 2017-10-20 | Wyeth Llc | Crystal forms of (r) -n-methylnaltrexone bromide and uses thereof. |
EP2066309B1 (en) | 2007-04-04 | 2012-08-29 | Sigmoid Pharma Limited | An oral pharmaceutical composition |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US20080260836A1 (en) * | 2007-04-18 | 2008-10-23 | Thomas James Boyd | Films Comprising a Plurality of Polymers |
EP2586428B1 (en) * | 2007-04-26 | 2023-11-08 | Sublimity Therapeutics Limited | Manufacture of multiple minicapsules |
JP2010526053A (en) * | 2007-05-01 | 2010-07-29 | シグモイド・ファーマ・リミテッド | Nimodipine pharmaceutical composition |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
WO2008157033A1 (en) * | 2007-06-20 | 2008-12-24 | Mcneil-Ppc, Inc | Products for whitening teeth |
EP2008651A1 (en) * | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
WO2009012353A2 (en) | 2007-07-19 | 2009-01-22 | Boston Scientific Limited | Endoprosthesis having a non-fouling surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
JP2010535541A (en) | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | Coating for medical devices with large surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
CN101152164B (en) * | 2007-09-14 | 2011-04-06 | 李世荣 | Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same |
CN101152163B (en) * | 2007-09-14 | 2010-05-26 | 李世荣 | Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
PE20091084A1 (en) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION |
CN101229174B (en) * | 2008-01-25 | 2010-12-15 | 广东一品红药业有限公司 | Antianaphylaxis compound containing epinastine hydrochloride |
EP2271380B1 (en) | 2008-04-22 | 2013-03-20 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20090304776A1 (en) * | 2008-06-06 | 2009-12-10 | Totada Shantha | Transmucosal delivery of therapeutic agents and methods of use thereof |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
EP2303350A2 (en) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
CN102056578A (en) * | 2008-06-23 | 2011-05-11 | 生物递送科学国际公司 | Multidirectional mucosal delivery devices and methods of use |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
WO2010017310A1 (en) | 2008-08-06 | 2010-02-11 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
US20110092493A1 (en) * | 2008-09-24 | 2011-04-21 | Clark Levi | Dose-controlled transdermal promethazine compositions and methods of use |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
CN102378684B (en) | 2009-04-02 | 2015-09-23 | 高露洁-棕榄公司 | Color changing consumer products |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
SI2432455T1 (en) | 2009-05-18 | 2015-04-30 | Sigmoid Pharma Limited | Composition comprising oil drops |
EP2432437A4 (en) * | 2009-05-21 | 2012-12-19 | Bionex Pharmaceuticals Llc | Dual and single layer dosage forms |
US8778278B2 (en) | 2009-07-15 | 2014-07-15 | General Electric Company | Non bio-adhesive polymer coating composition, articles and devices thereof |
US20110033515A1 (en) * | 2009-08-04 | 2011-02-10 | Rst Implanted Cell Technology | Tissue contacting material |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
EP2464341B1 (en) | 2009-08-12 | 2022-07-06 | Sublimity Therapeutics Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
US20110037455A1 (en) * | 2009-08-17 | 2011-02-17 | Oren Navot | System for measuring electrical power |
US8701671B2 (en) | 2011-02-04 | 2014-04-22 | Joseph E. Kovarik | Non-surgical method and system for reducing snoring |
US9549842B2 (en) | 2011-02-04 | 2017-01-24 | Joseph E. Kovarik | Buccal bioadhesive strip and method of treating snoring and sleep apnea |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
BR112012018449A2 (en) | 2010-01-29 | 2019-09-24 | Colgate Palmolive Co | dental treatment delivery strip |
TWI435733B (en) | 2010-01-29 | 2014-05-01 | Colgate Palmolive Co | Oral care formulations for malodor control |
US20110195042A1 (en) * | 2010-02-10 | 2011-08-11 | Thomas Edward Huetter | Compositions, Methods and Kits Useful for Treating a Respiratory Symptom |
JP5819329B2 (en) * | 2010-03-09 | 2015-11-24 | アルカーメス ファーマ アイルランド リミテッド | Alcohol-resistant enteric pharmaceutical composition |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US9572773B2 (en) * | 2010-04-26 | 2017-02-21 | Novartis A.G. | Layered drug delivery device |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US8951598B2 (en) * | 2010-05-07 | 2015-02-10 | Empire Technology Development Llc | Nanoscale collagen particles and membranes |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9161890B2 (en) | 2010-06-30 | 2015-10-20 | Colgate-Palmolive Company | Multilayer films for delivery of flavor |
BR112012030192A2 (en) * | 2010-06-30 | 2016-09-20 | Colgate Palmolive Co | multi-layer film flavor release during brushing |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
RU2013126437A (en) | 2010-11-08 | 2014-12-20 | Колгейт-Палмолив Компани | COMPOSITIONS FOR THE ORAL CAVITIES CONTAINING MICRO-UNITS |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
MX2013006637A (en) | 2010-12-13 | 2013-08-01 | Colgate Palmolive Co | Oral compositions and method for producing thereof. |
AU2010365421B2 (en) | 2010-12-13 | 2015-05-14 | Colgate-Palmolive Company | Oral compositions and method for producing thereof |
AU2010365419B2 (en) | 2010-12-13 | 2015-05-28 | Colgate-Palmolive Company | Oral compositions and method for producing thereof |
WO2012092594A2 (en) * | 2010-12-30 | 2012-07-05 | Harish Ziv M D | Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
WO2012123515A1 (en) | 2011-03-14 | 2012-09-20 | Drug Delivery Solutions Limited | An ophthalmic composition |
KR101328162B1 (en) | 2011-06-27 | 2013-11-13 | 조선대학교산학협력단 | fluorine agent of tape type using biodegradable polymers and manufacturing method thereof |
US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
EP2594257A1 (en) * | 2011-11-17 | 2013-05-22 | Labtec GmbH | Orodispersible films for the manufacturing of individualised medicine or for large scale production |
US20140186427A1 (en) * | 2011-08-12 | 2014-07-03 | Tesa Labtec Gmbh | Orodispersible films for the manufacturing of individualised medicine or for large scale production |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
GB201121300D0 (en) | 2011-12-12 | 2012-01-25 | Glaxo Group Ltd | Novel composition |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
WO2013110340A1 (en) * | 2012-01-27 | 2013-08-01 | Beta Pharma S.A. | Edible slow dissolving film for treating oral ulcerations |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
IN2014DN09031A (en) | 2012-03-30 | 2015-05-22 | Nuformix Ltd | |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
GB201304662D0 (en) | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
WO2014159798A1 (en) | 2013-03-13 | 2014-10-02 | Avery Dennison Corporation | Improving adhesive properties |
US20140271787A1 (en) | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Continuous single layer film structure including discrete domains |
US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
BR112016002205A2 (en) * | 2013-07-31 | 2017-08-01 | Bluepharma Ind Farmaceutica S A | orodispersible films |
EP3030278B1 (en) * | 2013-08-08 | 2018-09-19 | Boston Scientific Scimed, Inc. | Stent comprising a dissolvable or degradable adhesive polymer to prevent migration |
WO2015056196A1 (en) | 2013-10-16 | 2015-04-23 | Orahealth Corporation | Treating mucosal lesions with hyaluronan delivered from an adhering troche |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
RU2666212C2 (en) * | 2013-12-23 | 2018-09-06 | Колгейт-Палмолив Компани | Film compositions for oral use |
BR112016013893A2 (en) | 2013-12-23 | 2018-05-22 | Colgate Palmolive Co | oral care product for teeth whitening |
EP2889030A1 (en) * | 2013-12-30 | 2015-07-01 | Uluru Inc. | Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels |
WO2015120471A1 (en) * | 2014-02-10 | 2015-08-13 | The Johns Hopkins University | Devices for and methods of treatment of metabolic syndromes |
WO2015122477A1 (en) * | 2014-02-12 | 2015-08-20 | 沢井製薬株式会社 | Orally disintegrating tablet coated with film |
CN104845549B (en) * | 2014-02-18 | 2019-07-12 | 财团法人工业技术研究院 | Wood adhesive, wood adhesion method using same and wood joint structure |
US9970303B2 (en) | 2014-05-13 | 2018-05-15 | Entrotech, Inc. | Erosion protection sleeve |
JP6490791B2 (en) | 2014-07-31 | 2019-03-27 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Articles and methods for maintaining menstrual fluid in the vagina |
US11623008B2 (en) | 2014-08-20 | 2023-04-11 | Professional Compounding Centers Of America | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan |
CA2966801A1 (en) | 2014-11-07 | 2016-05-12 | Sigmoid Pharma Limited | Compositions comprising cyclosporin |
WO2016086095A1 (en) | 2014-11-25 | 2016-06-02 | Biodelivery Sciences International, Inc. | Patches, methods for forming and testing pharmaceutical agent delivery patches |
CN108135835A (en) | 2015-08-06 | 2018-06-08 | 约翰霍普金斯大学 | For treating the composition of metabolic disorder and method |
TWI564356B (en) | 2015-09-18 | 2017-01-01 | 財團法人工業技術研究院 | Wood adhesive |
WO2017085262A1 (en) * | 2015-11-19 | 2017-05-26 | Dermtreat Aps | A pharmaceutical film composition having improved residence time on the application site |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
US20210069122A1 (en) * | 2016-01-27 | 2021-03-11 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
KR20180107127A (en) * | 2016-01-28 | 2018-10-01 | 킴벌리-클라크 월드와이드, 인크. | Adhesive compositions for RNA viruses and methods for removing RNA viruses from surfaces |
WO2017192921A1 (en) | 2016-05-05 | 2017-11-09 | Monosol Rx, Llc | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
KR102627187B1 (en) | 2016-05-26 | 2024-01-22 | 킴벌리-클라크 월드와이드, 인크. | Anti-adhesion compositions and methods for inhibiting adhesion of microorganisms to surfaces |
WO2017222575A1 (en) | 2016-06-23 | 2017-12-28 | Collegium Pharmaceutical, Inc. | Process of making more stable abuse-deterrent oral formulations |
CN107865868B (en) | 2016-09-27 | 2020-04-10 | 上海微创医疗器械(集团)有限公司 | New application of amlexanox |
ES2874787T3 (en) | 2017-01-23 | 2021-11-05 | Afyx Therapeutics As | Method for the preparation of electrospun fibers with a high content of a bioadhesive substance |
JP7162014B2 (en) | 2017-01-23 | 2022-10-27 | アフリックス セラピューティクス アー/エス | Method for fabricating two-layer products based on electrospun fibers |
RU2699808C2 (en) * | 2017-12-05 | 2019-09-11 | Общество с ограниченной ответственностью "Эндокринные технологии" | Biodegradable system of transmucosal delivery of drotaverin |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
WO2019239356A1 (en) | 2018-06-15 | 2019-12-19 | R. J. Reynolds Tobacco Company | Purification of nicotine |
US11291654B2 (en) * | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
CN109953984A (en) * | 2019-03-01 | 2019-07-02 | 哈尔滨医科大学 | A kind of compound hydrochloric acid totokaine film and preparation method thereof |
MX2021010972A (en) * | 2019-03-14 | 2021-10-13 | Esocap Ag | Pharmaceutical dosage form for application to mucous membranes and methods for producing same. |
KR102234482B1 (en) * | 2019-05-14 | 2021-03-31 | 조선대학교산학협력단 | fluorine agent of dual film type using polymers with differential dissolution characteristics and manufacturing method thereof |
RU2729659C1 (en) * | 2019-05-29 | 2020-08-11 | Общество с ограниченной ответственностью "Эндокринные технологии" | Dosage form for releasing drotaverine in oral cavity |
CN113134085A (en) * | 2020-01-17 | 2021-07-20 | 四川大学华西第二医院 | Medicine for treating white lesions of vulva |
CN113181416B (en) * | 2021-04-26 | 2022-04-05 | 苏州和塑美科技有限公司 | Self-adhesive nanofiber antibacterial dressing easy to transfer and preparation method thereof |
CN114848612A (en) * | 2022-04-28 | 2022-08-05 | 青岛博益特生物材料股份有限公司 | Sheet material film coating process and film coated sheet material produced by same |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713243A (en) * | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
EP0275550A1 (en) * | 1986-12-24 | 1988-07-27 | Teikoku Seiyaku Kabushiki Kaisha | Adhesive device for application to body tissue |
EP0781546A1 (en) * | 1995-12-26 | 1997-07-02 | Sanwa Kagaku Kenkyusho Co., Ltd. | A multi-layered film preparation |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
EP0873750A1 (en) * | 1997-04-23 | 1998-10-28 | Permatec Technologie Ag | Bioadhesive tablets |
WO1999055312A2 (en) * | 1998-04-29 | 1999-11-04 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
WO2000032172A1 (en) * | 1998-11-27 | 2000-06-08 | Kanji Takada | An oral formulation for gastrointestinal drug delivery |
JP2001163745A (en) * | 1999-12-08 | 2001-06-19 | Lion Corp | Patch agent for oral use |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3993072A (en) | 1974-08-28 | 1976-11-23 | Alza Corporation | Microporous drug delivery device |
GB1593097A (en) | 1978-05-26 | 1981-07-15 | Fisons Ltd | Pharmaceutical compositions containing a bischromone |
JPS5562012A (en) | 1978-11-06 | 1980-05-10 | Teijin Ltd | Slow-releasing preparation |
GB2042888B (en) | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
US4286592A (en) | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
JPS5758615A (en) | 1980-09-26 | 1982-04-08 | Nippon Soda Co Ltd | Film agnent and its preparation |
JPS5770816A (en) | 1980-10-17 | 1982-05-01 | Ono Pharmaceut Co Ltd | Multilayered film preparation of prostagladin of prolonged action |
JPS57110254A (en) | 1980-12-29 | 1982-07-09 | Teijin Ltd | Coating agent of injured membrane part of oral cavity |
CH653550A5 (en) * | 1981-10-20 | 1986-01-15 | Sandoz Ag | PHARMACEUTICAL COMPOSITION FOR DELAYED RELEASE OF A MEDICINE IN THE ORAL AREA. |
US4518721A (en) | 1982-03-26 | 1985-05-21 | Richardson-Vicks Inc. | Hydrophilic denture adhesive |
CA1208558A (en) | 1982-10-07 | 1986-07-29 | Kazuo Kigasawa | Soft buccal |
JPS59186913A (en) | 1983-04-08 | 1984-10-23 | Teikoku Seiyaku Kk | Base to be applied to mucosa in oral cavity |
US4513243A (en) * | 1983-06-08 | 1985-04-23 | Westinghouse Electric Corp. | Core form transformer for selective cancellation of subsynchronous resonance |
JPH0830004B2 (en) | 1983-11-14 | 1996-03-27 | コロンビア ラボラトリーズ インコーポレイテッド | Bioadhesive composition and method of treatment therewith |
US5855908A (en) | 1984-05-01 | 1999-01-05 | University Of Utah Research Foundation | Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient |
US5783207A (en) | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
DE3714074A1 (en) | 1987-04-28 | 1988-11-10 | Hoechst Ag | BASIS FOR MUCUTINE AND PROSTHESISAL PASTE, METHOD FOR THEIR PRODUCTION AND PASTE BASED ON THIS BASE |
US4915948A (en) | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
JP2635336B2 (en) * | 1987-09-30 | 1997-07-30 | 帝國製薬株式会社 | Sustained release oral preparation |
US5081157A (en) | 1988-05-02 | 1992-01-14 | Zila Pharmaceuticals, Inc. | Compositions and in situ methods for forming films on body tissue |
US5081158A (en) | 1988-05-02 | 1992-01-14 | Zila Pharmaceuticals, Inc. | Compositions and in situ methods for forming films on body tissue |
US5047244A (en) | 1988-06-03 | 1991-09-10 | Watson Laboratories, Inc. | Mucoadhesive carrier for delivery of therapeutical agent |
JP2656338B2 (en) | 1989-01-31 | 1997-09-24 | 日東電工株式会社 | Oral mucosa patch preparation |
US6056930A (en) * | 1989-05-24 | 2000-05-02 | American Dental Association Health Foundation | Methods and compositions for mineralizing and fluoridating calcified tissues |
US5037639A (en) * | 1989-05-24 | 1991-08-06 | American Dental Association Health Foundation | Methods and compositions for mineralizing calcified tissues |
US5139023A (en) | 1989-06-02 | 1992-08-18 | Theratech Inc. | Apparatus and method for noninvasive blood glucose monitoring |
US6017521A (en) | 1989-10-31 | 2000-01-25 | Columbia Laboratories, Inc. | Use of polycarboxylic acid polymers to treat vaginal infections |
ES2050096T3 (en) | 1989-10-31 | 1995-01-16 | Columbia Lab Inc | HUMIDIFYING COMPOSITION OF THE VAGINAL TISSUE. |
ES2134769T3 (en) | 1989-10-31 | 1999-10-16 | Columbia Lab Bermuda Ltd | TISSUE HUMIDIFICATION PROCEDURE AND COMPOSITION. |
US5750134A (en) | 1989-11-03 | 1998-05-12 | Riker Laboratories, Inc. | Bioadhesive composition and patch |
US5750136A (en) | 1989-11-03 | 1998-05-12 | Riker Laboratories, Inc. | Bioadhesive composition and patch |
US5298258A (en) | 1989-12-28 | 1994-03-29 | Nitto Denko Corporation | Acrylic oily gel bioadhesive material and acrylic oily gel preparation |
US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
DE69312487T2 (en) | 1992-05-18 | 1997-11-27 | Minnesota Mining & Mfg | DEVICE FOR TRANSMUCOSAL DELIVERY OF ACTIVE SUBSTANCES |
US5543150A (en) | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
US5578315A (en) | 1993-12-01 | 1996-11-26 | Rutgers, The State University Of New Jersey | Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
US5458879A (en) | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US5639469A (en) | 1994-06-15 | 1997-06-17 | Minnesota Mining And Manufacturing Company | Transmucosal delivery system |
US6103226A (en) * | 1994-08-12 | 2000-08-15 | Arch Development Corporation | Genetically engineered cells that produce produce L. Dopa |
AU3726395A (en) | 1994-09-27 | 1996-04-19 | Virotex Corporation | Improved topical carriers for mucosal applications |
US5667492A (en) | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5888534A (en) | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
CA2184316A1 (en) | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
IT1277663B1 (en) | 1995-09-28 | 1997-11-11 | Crinos Industria Farmaco | STABLE AQUEOUS SUSPENSIONS OF MESALAZINE FOR TOPICAL USE |
US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US5849322A (en) | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
US5889028A (en) | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5955098A (en) | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
US5869082A (en) | 1996-04-12 | 1999-02-09 | Flemington Pharmaceutical Corp. | Buccal, non-polar spray for nitroglycerin |
DE69732412T2 (en) | 1996-04-12 | 2006-01-05 | Novadel Pharma Inc. | BUKALES, POLAR SPRAY |
GB9610862D0 (en) * | 1996-05-23 | 1996-07-31 | Evans Brian K | Pharmaceutical products |
SE9602644D0 (en) | 1996-07-04 | 1996-07-04 | Astra Ab | New use |
US5861174A (en) | 1996-07-12 | 1999-01-19 | University Technology Corporation | Temperature sensitive gel for sustained delivery of protein drugs |
US5955097A (en) | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
US5900230A (en) | 1997-08-18 | 1999-05-04 | Squigle, Inc. | Dental products to treat and prevent periodontal disease |
US5981499A (en) | 1998-02-20 | 1999-11-09 | Atlantic Biomed Corporation | Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
US6103266A (en) | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
GB9812426D0 (en) | 1998-06-10 | 1998-08-05 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
US6284262B1 (en) | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
US6117446A (en) | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
EP2275133A1 (en) | 1999-02-26 | 2011-01-19 | Novartis Vaccines and Diagnostics, Inc. | Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
US6649147B1 (en) * | 1999-07-02 | 2003-11-18 | The Procter & Gamble Company | Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip |
BRPI0109371B1 (en) * | 2000-03-17 | 2016-02-16 | Lg Household & Health Care Ltd | dry type dental bleaching plasters |
US6689344B2 (en) * | 2000-03-17 | 2004-02-10 | Lg Household & Healthcare Ltd. | Patches for teeth whitening |
IT1318649B1 (en) | 2000-07-28 | 2003-08-27 | Propharma S R L Ora Sinclair P | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS. |
US6419906B1 (en) * | 2001-03-12 | 2002-07-16 | Colgate Palmolive Company | Strip for whitening tooth surfaces |
US6946142B2 (en) * | 2001-06-23 | 2005-09-20 | Lg Household & Healthcare Ltd. | Multi-layer patches for teeth whitening |
US20060073174A1 (en) * | 2001-08-16 | 2006-04-06 | Access Pharmaceuticals, Inc. | Adherent and erodible film to treat a moist surface of a body tissue |
-
2001
- 2001-08-16 US US09/931,319 patent/US6585997B2/en not_active Expired - Lifetime
-
2002
- 2002-08-16 RU RU2004107575/15A patent/RU2343903C2/en not_active IP Right Cessation
- 2002-08-16 MX MXPA04001491A patent/MXPA04001491A/en unknown
- 2002-08-16 JP JP2003520708A patent/JP2005504763A/en active Pending
- 2002-08-16 CA CA002459692A patent/CA2459692A1/en not_active Abandoned
- 2002-08-16 EP EP02761390A patent/EP1418889A2/en not_active Withdrawn
- 2002-08-16 PL PL02373327A patent/PL373327A1/en unknown
- 2002-08-16 IL IL16041902A patent/IL160419A0/en unknown
- 2002-08-16 CN CN201010171156A patent/CN101849924A/en active Pending
- 2002-08-16 KR KR10-2004-7002303A patent/KR20040039290A/en not_active Application Discontinuation
- 2002-08-16 HU HU0401281A patent/HUP0401281A3/en unknown
- 2002-08-16 WO PCT/US2002/026083 patent/WO2003015748A2/en active IP Right Grant
- 2002-08-16 AU AU2002326664A patent/AU2002326664B2/en not_active Ceased
- 2002-08-16 NZ NZ531766A patent/NZ531766A/en not_active IP Right Cessation
- 2002-08-16 CN CNA028183274A patent/CN1738599A/en active Pending
-
2003
- 2003-05-23 US US10/444,512 patent/US20040062724A1/en not_active Abandoned
-
2004
- 2004-02-16 IL IL160410A patent/IL160410A/en not_active IP Right Cessation
- 2004-02-16 IS IS7155A patent/IS7155A/en unknown
- 2004-03-15 ZA ZA200402067A patent/ZA200402067B/en unknown
-
2010
- 2010-02-26 JP JP2010041418A patent/JP2010159268A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713243A (en) * | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
EP0275550A1 (en) * | 1986-12-24 | 1988-07-27 | Teikoku Seiyaku Kabushiki Kaisha | Adhesive device for application to body tissue |
EP0781546A1 (en) * | 1995-12-26 | 1997-07-02 | Sanwa Kagaku Kenkyusho Co., Ltd. | A multi-layered film preparation |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
EP0873750A1 (en) * | 1997-04-23 | 1998-10-28 | Permatec Technologie Ag | Bioadhesive tablets |
WO1999055312A2 (en) * | 1998-04-29 | 1999-11-04 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
WO2000032172A1 (en) * | 1998-11-27 | 2000-06-08 | Kanji Takada | An oral formulation for gastrointestinal drug delivery |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
JP2001163745A (en) * | 1999-12-08 | 2001-06-19 | Lion Corp | Patch agent for oral use |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Section Ch Week 200168, Derwent World Patents Index; Class A11, AN 2001-599816, XP002237282 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858978B2 (en) | 2004-09-28 | 2014-10-14 | Atrium Medical Corporation | Heat cured gel and method of making |
US8962023B2 (en) | 2004-09-28 | 2015-02-24 | Atrium Medical Corporation | UV cured gel and method of making |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9220820B2 (en) | 2005-10-15 | 2015-12-29 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
US9592324B2 (en) | 2006-11-06 | 2017-03-14 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
Also Published As
Publication number | Publication date |
---|---|
RU2004107575A (en) | 2005-04-20 |
US6585997B2 (en) | 2003-07-01 |
IL160410A (en) | 2009-08-03 |
CN1738599A (en) | 2006-02-22 |
CA2459692A1 (en) | 2003-02-27 |
HUP0401281A3 (en) | 2008-04-28 |
US20030044446A1 (en) | 2003-03-06 |
IL160410A0 (en) | 2004-09-27 |
HUP0401281A2 (en) | 2004-11-29 |
US20040062724A1 (en) | 2004-04-01 |
EP1418889A2 (en) | 2004-05-19 |
JP2005504763A (en) | 2005-02-17 |
IL160419A0 (en) | 2004-09-27 |
JP2010159268A (en) | 2010-07-22 |
KR20040039290A (en) | 2004-05-10 |
ZA200402067B (en) | 2005-05-28 |
PL373327A1 (en) | 2005-08-22 |
MXPA04001491A (en) | 2004-05-17 |
CN101849924A (en) | 2010-10-06 |
NZ531766A (en) | 2005-12-23 |
WO2003015748A2 (en) | 2003-02-27 |
RU2343903C2 (en) | 2009-01-20 |
AU2002326664B2 (en) | 2008-03-06 |
IS7155A (en) | 2004-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003015748A3 (en) | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds | |
ATE288743T1 (en) | PHARMACEUTICAL CARRIER DEVICE SUITABLE FOR ADMINISTRATION OF ACTIVE INGREDIENTS TO MUCOUS SKIN SURFACES | |
ES2188907T3 (en) | APPROPRIATE PHARMACEUTICAL SUPPORT DEVICE FOR THE ADMINISTRATION OF PHARMACEUTICAL COMPOUNDS TO THE MUCOSE SURFACES. | |
WO2002003969A3 (en) | Transdermal therapeutic system for highly dispersed silicon dioxide | |
DK0957900T3 (en) | Compositions and Methods for Topical Application of Therapeutic Agents | |
AP2003002922A0 (en) | Skin-permeable selective cyclooxygenase-2 inhibitor composition. | |
WO2001003917A3 (en) | Multilayered film containing an active substance and made of cross-linked hydrophilic polymers | |
CA2214033A1 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent | |
WO2005007139A3 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
BRPI0412557A (en) | pharmaceutical dosage form of cardiovascular events | |
WO2005082428A3 (en) | Plaster that reduces skin irritation | |
WO2001066095A1 (en) | Stretchable patch | |
WO1997020582A3 (en) | Transdermal patch for comparative evaluations | |
BRPI0406858A (en) | Controlled release of highly soluble agents | |
CN101155578A (en) | Method for a treatment with a medicament combination and medicament combinations suitable for the same | |
AU2003226695B2 (en) | Assembled unit consisting of individually separable transdermal therapeutic systems | |
WO1994017792A3 (en) | Compositions and methods for transdermal drug delivery | |
AR042102A1 (en) | DERMIC ADMINISTRATION OF A CYCLLOXYGENASA INHIBITOR - 2 WATER SOLUBLE SELECTIVE | |
NZ535611A (en) | Pharmaceutical composition of a PDE4 or a PDE3/4 inhibitor and a histamine receptor antagonist | |
AU4035499A (en) | Laminate for application onto an acceptor | |
US20050118245A1 (en) | Assembled unit consisting of individually separable, transdermal, therapeutic systems | |
WO2003059284A3 (en) | Composition and method for inhibiting hypersensitivity | |
BR0212506A (en) | Transdermal administration of an enalapril ester | |
WO2005079272A3 (en) | Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines | |
LV10749A (en) | Transdermal therapeutic system for the application of physostigmine to the skin and its manufacturing tolerance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG US Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003520708 Country of ref document: JP Ref document number: 160419 Country of ref document: IL Ref document number: 373327 Country of ref document: PL Ref document number: PA/A/2004/001491 Country of ref document: MX Ref document number: 1020047002303 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002326664 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004/02067 Country of ref document: ZA Ref document number: 200402067 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 531766 Country of ref document: NZ Ref document number: 2002761390 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2459692 Country of ref document: CA Ref document number: 20028183274 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002761390 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 531766 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 531766 Country of ref document: NZ |